Charles Schwab Investment Management Inc Abb Vie Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 22,717,314 shares of ABBV stock, worth $3.66 Billion. This represents 0.96% of its overall portfolio holdings.
Number of Shares
22,717,314
Previous 24,451,975
7.09%
Holding current value
$3.66 Billion
Previous $3.79 Billion
9.17%
% of portfolio
0.96%
Previous 0.97%
Shares
27 transactions
Others Institutions Holding ABBV
# of Institutions
3,643Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.6M-
Vanguard Group Inc Valley Forge, PA170MShares$27.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$23.1 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$12.6 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.26 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$7.76 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $285B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...